- Home
- NHS vs ARAY Comparison
NHS vs ARAY Comparison
Compare NHS & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHS
- ARAY
- Stock Information
- Founded
- NHS 2003
- ARAY 1990
- Country
- NHS United States
- ARAY United States
- Employees
- NHS N/A
- ARAY N/A
- Industry
- NHS Trusts Except Educational Religious and Charitable
- ARAY Medical/Dental Instruments
- Sector
- NHS Finance
- ARAY Health Care
- Exchange
- NHS Nasdaq
- ARAY Nasdaq
- Market Cap
- NHS 213.4M
- ARAY 171.0M
- IPO Year
- NHS N/A
- ARAY 2007
- Fundamental
- Price
- NHS $7.65
- ARAY $1.83
- Analyst Decision
- NHS
- ARAY Strong Buy
- Analyst Count
- NHS 0
- ARAY 1
- Target Price
- NHS N/A
- ARAY $9.00
- AVG Volume (30 Days)
- NHS 111.8K
- ARAY 636.1K
- Earning Date
- NHS 01-01-0001
- ARAY 11-06-2024
- Dividend Yield
- NHS 13.44%
- ARAY N/A
- EPS Growth
- NHS N/A
- ARAY N/A
- EPS
- NHS N/A
- ARAY N/A
- Revenue
- NHS N/A
- ARAY $444,204,000.00
- Revenue This Year
- NHS N/A
- ARAY $6.33
- Revenue Next Year
- NHS N/A
- ARAY $5.60
- P/E Ratio
- NHS N/A
- ARAY N/A
- Revenue Growth
- NHS N/A
- ARAY N/A
- 52 Week Low
- NHS $6.95
- ARAY $1.40
- 52 Week High
- NHS $9.17
- ARAY $3.05
- Technical
- Relative Strength Index (RSI)
- NHS 27.55
- ARAY 48.86
- Support Level
- NHS $7.96
- ARAY $1.67
- Resistance Level
- NHS $8.16
- ARAY $2.15
- Average True Range (ATR)
- NHS 0.13
- ARAY 0.13
- MACD
- NHS -0.04
- ARAY -0.01
- Stochastic Oscillator
- NHS 0.94
- ARAY 33.33
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.